Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

NMR vs FUTU: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

FUTU Wins Head-to-Head Institutional Verdict (4–1 across 6 Pillars · 7–3 Matrix Metrics)

FUTU Overall Winner 6-Pillar Tally: NMR 1 – 4 FUTU (1 Tie) Matrix Metrics: NMR 3 – 7 FUTU

As of Nov 17, 2026, Futu Holdings Limited (FUTU) is the stronger overall head-to-head candidate over Nomura Holdings, Inc (NMR) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). NMR carries a Unified Composite Score of 44.5/100 (HOLD) at $9.34 (12.7x Forward P/E, 25.1% operating margin), whereas FUTU carries 47.3/100 (HOLD) at $87.34 (8.6x Forward P/E, 66.7% operating margin).

  • Technical & Structure Timing Caution: NMR trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 45.5); meanwhile FUTU is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About NMR vs FUTU
NMR NYSE
Nomura Holdings, Inc
Security Brokers, Dealers & Flotation Companies
$9.34
-1.74% 1D
Market Cap $28.3B
TTM Revenue $14.9B
Forward P/E 12.7x
Beta / 30D Vol 1.03β · 29% Vol
Unified Composite Score
44.5 / 100 HOLD
Tech 47.0 Fund 49.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 45
RSI-14: 45.5 · SMA20: $9.40 · SMA50: $9.68
FUTU NASDAQ Head-to-Head Winner
Futu Holdings Limited American Depositary Shares
Security Brokers, Dealers & Flotation Companies
$87.34
-4.65% 1D
Market Cap $13.4B
TTM Revenue $3.06B
Forward P/E 8.6x
Beta / 30D Vol 1.79β · 49% Vol
Unified Composite Score
47.3 / 100 HOLD
Tech 33.0 Fund 48.0 Flow 50.0 Mom 68.9
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -6.3%), weak momentum, RSI 33
RSI-14: 32.5 · SMA20: $98.46 · SMA50: $105.72

6-Pillar Scorecard Institutional Category Breakdown (NMR 1 – 4 FUTU)

Columns: Metric · NMR · FUTU
1. Valuation Multiples FUTU
Forward P/E 12.7x 8.6x
Trailing P/E 11.2x 9.5x
PEG Ratio 0.81x N/M
EV / Revenue 1.9x 4.4x
2. Growth & Scale FUTU
Revenue Growth (YoY) +17.9% +35.6%
Earnings Growth (YoY) +13.6% +43.0%
TTM Revenue (USD) $14.9B $3.06B
Market Cap $28.3B $13.4B
3. Profitability & Quality FUTU
Gross Margin 77.4% 94.1%
Operating Margin 25.1% 66.7%
Net Profit Margin 17.1% 46.2%
Return on Equity (ROE) 11.5% 30.5%
4. Balance Sheet & Cash Flow FUTU
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage $8.17 Book/Sh · 11.5% ROE $35.71 Book/Sh · 30.5% ROE
Dividend Yield 3.34% None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 30.7% (<1st %ile) 49.3% (20th %ile)
Put/Call OI Skew Thin ADR Chain Thin ADR Chain
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat NMR
OpEx & R&D Intensity 52.3% of Rev ($7.77B) 27.4% of Rev ($838M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat High-Margin Pricing Power Moat
Supply-Chain Role Capital Markets Operator Capital Markets Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: NMR (3) vs FUTU (7)
Institutional Metric NMR FUTU Criterion Row Edge
Market Capitalization
Scale
$28.3B $13.4B Larger Scale NMR
Trailing P/E Ratio
Valuation
11.2x 9.5x Lower Multiple FUTU
Forward P/E Ratio
Valuation
12.7x 8.6x Lower Multiple FUTU
Revenue Growth (YoY)
Growth
+17.9% +35.6% Higher Growth FUTU
Operating Margin (TTM)
Profitability
25.1% 66.7% Higher Margin FUTU
Net Profit Margin
Profitability
17.1% 46.2% Higher Margin FUTU
Return on Equity (ROE)
Capital Efficiency
11.5% 30.5% Higher ROE FUTU
52-Week Range Position
Momentum
60% ($7–$11) 6% ($80–$189) Stronger Trend NMR
Beta / 30D Volatility
Risk Regime
1.03β · 29% Vol 1.79β · 49% Vol Lower Realized Risk NMR
Unified Institutional Score
Composite Signal
44.5 / 100 (HOLD) 47.3 / 100 (HOLD) Higher Composite FUTU
Trailing 12M Revenue (USD)
Operating Scale
$14.9B $3.06B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
77.4% 94.1% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.81x PEG · 1.9x EV/Rev N/M PEG · 4.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A ($8.17 Book/Sh · 11.5% ROE) N/A ($35.71 Book/Sh · 30.5% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon NMR +19.57 pp
NMR: +2.36% · FUTU: -17.21%
3M Horizon NMR +18.34 pp
NMR: -1.84% · FUTU: -20.18%
6M Horizon NMR +46.54 pp
NMR: +16.69% · FUTU: -29.85%
1Y Horizon NMR +73.63 pp
NMR: +26.32% · FUTU: -47.31%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NMR vs FUTU. Trailing 12-month operating profitability (NMR 25.1% vs FUTU 66.7%) and valuation multiples (NMR 12.7x vs FUTU 8.6x Forward P/E) are benchmarked directly in Pillar 4 below.

NMR ADR TTM Benchmark FX-Normalized USD
TTM Revenue$14.9B
Gross Margin77.4%
Op. Margin25.1%
ROE / Fwd P/E11.5% · 12.7x
FUTU ADR TTM Benchmark FX-Normalized USD
TTM Revenue$3.06B
Gross Margin94.1%
Op. Margin66.7%
ROE / Fwd P/E30.5% · 8.6x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
NMR UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 30.7%
IV Percentile <1st %ile
Put/Call OI Skew Thin ADR Chain
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact NMR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
FUTU UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 49.3%
IV Percentile 20th %ile
Put/Call OI Skew Thin ADR Chain
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact FUTU Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
NMR Moat Profile Scale & Operating Efficiency Moat
Capital Markets Operator
Competes within the Capital Markets value chain with $28.3B market capitalization and 25.1% operating margin.
OpEx & R&D Reinvestment 52.3% of Rev ($7.77B)
90D Engineering Disclosures 0 Published
FUTU Moat Profile High-Margin Pricing Power Moat
Capital Markets Operator
Competes within the Capital Markets value chain with $13.4B market capitalization and 66.7% operating margin.
OpEx & R&D Reinvestment 27.4% of Rev ($838M)
90D Engineering Disclosures 0 Published

Investor FAQ NMR vs FUTU Key Questions & Quantitative Answers

As of Nov 17, 2026, Futu Holdings Limited (FUTU) is the stronger overall head-to-head candidate over Nomura Holdings, Inc (NMR) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). NMR carries a Unified Composite Score of 44.5/100 (HOLD) at $9.34 (12.7x Forward P/E, 25.1% operating margin), whereas FUTU carries 47.3/100 (HOLD) at $87.34 (8.6x Forward P/E, 66.7% operating margin). Technical & Structure Timing Caution: NMR trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 45.5); meanwhile FUTU is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

FUTU leads the Growth & Scale pillar: NMR posts +17.9% YoY revenue growth and +13.6% YoY earnings growth on $14.9B TTM revenue (77.4% gross margin, 25.1% operating margin), compared with FUTU at +35.6% YoY revenue growth and +43.0% YoY earnings growth on $3.06B TTM revenue (94.1% gross margin, 66.7% operating margin). On trailing 12-month operating scale, NMR generates $14.9B in USD-normalized revenue versus $3.06B for FUTU. In operating R&D and SG&A reinvestment, NMR deploys 52.3% of Rev ($7.77B) (0 90-day corporate R&D disclosures) versus 27.4% of Rev ($838M) (0 disclosures) for FUTU.

FUTU screens cheaper on headline valuation multiples. NMR trades at 12.7x Forward P/E, 11.2x Trailing P/E, 0.81x PEG, and 1.9x EV/Revenue (unreported cash flow margin), whereas FUTU trades at 8.6x Forward P/E, 9.5x Trailing P/E, N/M PEG, and 4.4x EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against NMR (11.5% ROE) versus FUTU (30.5% ROE) capital efficiency.

In options market volatility and institutional positioning, NMR carries 30.7% implied volatility (<1st %ile, Compressed (<25th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.03β · 29% Vol realized risk). By comparison, FUTU carries 49.3% implied volatility (20th %ile, Compressed (<25th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.79β · 49% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.